Improvements in current antibiotics, cancer medications, and psoriasis treatments show exceptional promise as market drivers. And, according to this report from Frost & Sullivan, effective cancer medications have the potential to capture at least double their present revenue share. The report provides a strategic and competitive overview of the European market, highlighting recent joint research projects, developments, and licensing agreements. Consumer demands are outlined, and the specific concerns of each country are detailed. The report offers a comprehensive quantitative and qualitative analysis of each major segment and trend. 50 market profiles include companies like Roehm Pharma, Ciba AG, Basotherm, Immuno, and Fabre.
(0 items)
